Acadia Healthcare Company (ACHC) Cost of Revenue (2010 - 2026)

Acadia Healthcare Company (ACHC) has 17 years of Cost of Revenue data on file, last reported at $131.1 million in Q1 2026.

• Quarterly Cost of Revenue rose 362.49% year-over-year to $131.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $326.7 million (up 14.12% YoY) and the FY2025 annual result came in at $118.0 million, down 73.22% from the prior year.
• Cost of Revenue rose to $131.1 million in Q1 2026 per ACHC's latest filing, from $30.8 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $309.6 million in Q4 2023 and bottomed at $26.7 million in Q1 2024.
• The 5-year median for Cost of Revenue is $89.0 million (2022), against an average of $99.6 million.
• Peak annual rise in Cost of Revenue reached 382.15% in 2025, while the deepest fall reached 73.91% in 2025.
• Tracing ACHC's Cost of Revenue over 5 years: stood at $275.0 million in 2022, then advanced by 12.59% to $309.6 million in 2023, then plunged by 61.92% to $117.9 million in 2024, then sank by 73.91% to $30.8 million in 2025, then surged by 326.12% to $131.1 million in 2026.
• Per Business Quant, the three latest ACHC Cost of Revenue figures stand at $131.1 million (Q1 2026), $30.8 million (Q4 2025), and $30.4 million (Q3 2025).

Peer Comparison